News

Sarepta: TD Cowen downgrades rating, cuts PT on FDA pullback risk for Elevidys
Investing.com-- TD Cowen downgraded its rating on Sarepta Therapeutics Inc (NASDAQ: SRPT) and slashed its price target ...